From September 22 to 24, the 2nd China Biopharmaceutical Industry Conference 2026 was held in Nanjing. The event gathered numerous professionals across the biopharmaceutical industrial chain, with more than 2,000 attendees including experts, scholars, university delegates and enterprise representatives from over 500 organizations, alongside more than 40 exhibition booths. During the conference, Baino Chuangrui (Wenzhou) Biotech Co., Ltd. (Chuangrui Biotech) showcased at Booth A13, engaging in face-to-face communications with clients and industry partners around our one-stop CDMO capabilities for biomacromolecules.

Booth A13 | In-depth On-site Communication

At the exhibition, clients communicated with our team regarding process development, technical route design, scale-up, specialty formulation and commercial manufacturing of biotherapeutics such as recombinant proteins and antibodies. Covering early-stage process development and technical challenges as well as pilot scale-up and formulation supply for commercialization, our team discussed tailored technical solutions based on project experience, moving conversations from capability awareness toward concrete project collaboration.

Bring Your Project, Discuss Based on Your Needs
Booth A13 serves not only as a window to demonstrate Chuangrui Biotech’s CDMO capabilities, but also as a vital communication platform bridging client requirements and technical solutions.

• Technical Sharing | Focus on Recombinant Cell Growth Factor Process Development
  During the conference, General Manager Wang Shumin delivered a presentation titled “Analysis of Common Issues and Characterization Strategies in Process Development of Recombinant Cell Growth Factor Drugs” at the recombinant protein drug session.
  Combined with practical project experience, the presentation covered key segments including strain construction, fermentation expression, purification process and quality characterization, shared common challenges and corresponding mitigation strategies encountered in the process development of recombinant cell growth factor drugs, to provide practical references for industry peers.

Booth communications bridge industrial demands; technical sharing sparks professional insights.
Gathered in Jinling | Looking forward to our next encounter.

From on-site booth discussions to technical presentations, from project requirement consultation to collaboration negotiation, this three-day trip in Nanjing brought us face-to-face exchanges and deep connections across the biotech value chain.

Thank you to every client and partner who visited our booth.
Going forward, Chuangrui Biotech will continue to uphold the philosophy of "Technological Innovation, Customer First", and keep upgrading our one-stop CDMO service portfolio for biomacromolecules, to deliver reliable technical and manufacturing support for innovative drug R&D and commercialization.
The exhibition ends, yet our collaboration continues.
We look forward to meeting you again.